Table 1. Overview of Leishmania infantum strains used.
Origin and drug-susceptibility profile to the current antileishmania drugs (R: resistant; S: susceptible; [R]: resistant after experimental selection).
| L. infantum strain | Code | Origin | Drug susceptibility profile | |||
|---|---|---|---|---|---|---|
| SbV | SbIII | MIL | PMM | |||
| ITMAP263 | MHOM/MA/67/ITMAP263 | Laboratory reference strain | S | S | S | S |
| LEM3049 | MHOM/FR/95/LEM3049 | French field isolate from HIV+ patient | S | S | S | S |
| L3015 | MHOM/BR/2007/WC | Brazilian field isolate from HIV+ patient | S | S | S | S |
| LEM3323 | MHOM/FR/96/LEM3323 | French field isolate from HIV+ patient | R | R | S | S |
| LEM3323/MIL | Experimentally selected MIL-resistant strain | R | R | [R] | S | |
| LEM3323/PMM | Experimentally selected PMM-resistant strain | R | R | S | [R] | |